US$ 24.71
tirzepatide for prediabetes Cuts Risk of Diabetes by 94% in Prediabetic Adults The Weight Loss Drug That
Description
Compared to those receiving neither medication, all-cause mortality was significantly lower among patients treated with SGLT2-I only (HR 0.28, 95% CI 0.270.29), GLP-1RA only (HR 0.39, 95% CI 0.370.40) and both agents (HR 0.17, 95% CI 0.160.18)

Metabolic Support Improves glucose regulation and insulin function

The MACE event rate was comparable across weight loss categories (no loss/gain: 1.05%; 10% loss: 0.89%)
Enhanced with Vitamin C and Hyaluronic Acid